Literature DB >> 19937096

Late thromboembolic events after circumferential pulmonary vein ablation of atrial fibrillation.

Hailong Tao1, Changsheng Ma, Jianzeng Dong, Xingpeng Liu, Deyong Long, Ronghui Yu.   

Abstract

BACKGROUND: Catheter ablation can restore sinus rhythm in selected patients with atrial fibrillation (AF), but its preventive function for thromboembolic events (TE) is still underdetermined.
METHODS: We retrospectively studied 520 consecutive patients with AF who were referred for circumferential pulmonary vein ablation. The incidence of late TE was investigated, and the predictors of late TE were identified from analysis of the basic clinical variables of patients with late TE.
RESULTS: Eight (1.5%) patients experienced late TE during 28+/-8 months follow-up. When TE occurred, most (6/8, 75%) patients were documented with recurrence episode. The recurrence of AF was more frequent in patients with late TE than patients without late TE (75.0% vs 30.5%, P=0.007). Multivariate logistic regression analysis identified that all risk factors, including all clinical variants prior ablation and the CHADS2 score, were not related to late TE but the presence of recurrence was the only predictor of late TE (odds ratio, 5.542; 95% confidence interval [1.416-45.013], P=0.019).
CONCLUSIONS: Our study demonstrates a strong relationship between the recurrence after ablation and TE post-operation and supports the proposal that free of recurrence is an indication for discontinuation of anticoagulation after ablation.

Entities:  

Mesh:

Year:  2010        PMID: 19937096     DOI: 10.1007/s10840-009-9455-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  18 in total

Review 1.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

2.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

5.  Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: a randomized comparison between two different isolation approaches.

Authors:  Xingpeng Liu; Jianzeng Dong; Hercules E Mavrakis; Fuli Hu; Deyong Long; Dongping Fang; Ronghui Yu; Ribo Tang; Peng Hao; Chunshan Lu; Xiaokui He; Xiaohui Liu; Panos E Vardas; Changsheng Ma
Journal:  J Cardiovasc Electrophysiol       Date:  2006-12

6.  Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation.

Authors:  Hakan Oral; Srikar Veerareddy; Eric Good; Burr Hall; Peter Cheung; Kamala Tamirisa; Jihn Han; Jackie Fortino; Aman Chugh; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  J Cardiovasc Electrophysiol       Date:  2004-08

7.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

8.  Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.

Authors:  Feifan Ouyang; Dietmar Bänsch; Sabine Ernst; Anselm Schaumann; Hitoshi Hachiya; Minglong Chen; Julian Chun; Peter Falk; Afsaneh Khanedani; Matthias Antz; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

9.  Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment.

Authors:  Antonio Rossillo; Aldo Bonso; Sakis Themistoclakis; Giuseppe Riccio; Michela Madalosso; Andrea Corrado; Bruno De Piccoli; Antonio Raviele
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-01       Impact factor: 2.160

10.  Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Authors: 
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

View more
  3 in total

Review 1.  Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation.

Authors:  Andreas Rillig; Tina Lin; Feifan Ouyang; Karl Heinz Kuck; Roland Richard Tilz
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 2.  Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?

Authors:  Tze-Fan Chao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Fa-Po Chung; Jo-Nan Liao; Shih-Ann Chen
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

3.  Stroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.

Authors:  Tze-Fan Chao; Chern-En Chiang; Shih-Ann Chen
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.